全球将疫苗纳入预防接种日程:范围综述
该范围综述分析全球新疫苗纳入接种日程的过程,检索获2432条文献,去重后评估1744篇标题和摘要,最终纳入75项研究。多数研究显示纳入评估主要旨在降低成本及促进社会经济效益,多聚焦12岁以下儿童接种日程,常用成本效果与成本效益分析及增量成本效果比等工具。
要点
- 多数纳入研究报告新疫苗纳入评估主要旨在降低成本及促进集体与个人社会经济效益。
- 多数研究聚焦12岁以下儿童接种日程。
- 评估社会经济方面常用成本效果与成本效益分析,工具包括增量成本效果比、伤残调整寿命年、质量调整寿命年与马尔可夫模型。
核心结论
- 疫苗纳入过程已显示超出即时健康影响,涵盖社会改善与成本优化,能够产生长期效应。
研究设计与样本
- 范围综述,依据2024年乔安娜布里格斯研究所证据综合手册实施,并按系统综述与Meta分析首选报告条目扩展版范围综述指南报告。
主要发现
- 检索策略获得2432条引文,其中688条因重复被移除,随后评估1744篇标题和摘要,最终75项研究纳入综述。
- 多数纳入研究发现新疫苗纳入评估过程主要旨在降低成本及促进集体与个人社会经济效益,多数聚焦12岁以下儿童接种日程。
- 评估社会经济方面主要策略为新疫苗纳入的成本效果与成本效益分析,最常用工具包括增量成本效果比、伤残调整寿命年、质量调整寿命年与马尔可夫模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Over the past 50 years, immunization initiatives and programs promoted by member countries of the World Health Organization have prevented approximately 154 million deaths, 146 million of which would have occurred among children under 5 years of age. The development of vaccines and implementing global immunization strategies against vaccine-preventable diseases have been instrumental in enhancing global health security. OBJECTIVE: To analyze the process of integrating new vaccines into vaccination schedules worldwide. METHODOLOGY: This study is a scoping review, conducted in accordance with the 2024 Joanna Briggs Institute Manual for Evidence Synthesis and reported following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses - Extension for Scoping Reviews RESULTS: The search strategy yielded 2432 citations, with 688 removed due to duplication. Consequently, 1744 titles and abstracts were assessed, resulting in 75 studies being included in the review. The majority of these studies found that the assessment process for incorporating new vaccines primarily aims at reducing costs and/or promoting collective and individual social and economic benefits, with most focusing on the vaccination schedule for children up to 12 years of age. To evaluate the social and economic aspects, the predominant strategies were cost-effectiveness and cost-benefit analyses of new vaccine incorporation. The most frequently employed tools included the incremental cost-effectiveness ratio, years of life lost adjusted for disability, years of life adjusted for quality, and the Markov model. FINAL CONSIDERATIONS: The process of vaccine incorporation has been shown to extend beyond immediate health impacts, encompassing social improvements and cost optimization capable of producing long-term effects.
引用
- de Melo Araújo AC, Oliveira TM, Souza JFA, et al. Incorporating vaccines into vaccination schedules around the world: A scoping review. Vaccine. 2025. PMID: 40250066. doi:10.1016/j.vaccine.2025.127132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。